A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
Acerta Pharma BV
Massive Bio, Inc.
Incyte Corporation
BerGenBio ASA
Taproot Health
Sumitomo Pharma America, Inc.
Celgene
Celgene
Novartis
INSYS Therapeutics Inc
Novartis